Physical AI News (Japan)

Physical AI, robotics and compute — reported from Japan.

日本語
· Funding· 日本語で読む

Mingshi Naoji completes two funding rounds, raising more than 500 million yuan in total, leaderobot.com reports

Mingshi Naoji Technology (Suzhou) Co., Ltd. completed two funding rounds, bringing its total fundraising since founding to more than 500 million yuan. Puhua Capital led the earlier round, while Shanghai Science and Technology Innovation Group and Minjintou jointly led the later round, according to the report. Progress on system development and clinical evaluation will be a key measure of commercialization prospects.

What happened

leaderobot.com reported on Nov. 16, 2026, that Mingshi Naoji Technology (Suzhou) Co., Ltd. had completed two consecutive funding rounds, raising more than 500 million yuan in total during its two years since founding. Puhua Capital led the earlier round, while Shanghai Science and Technology Innovation Group and Minjintou jointly led the later round, the report said.

Why it matters

The company is working on cortical vision restoration, and Tencent News cited development of a 1,024-channel system, preparation for registration testing and a multicenter clinical study as planned uses for the funding. The total raised alone does not indicate that clinical evaluation has been completed or that registration has been obtained, so progress on system development and evaluation will be key to assessing the technology’s commercialization prospects.

Analysis

The figure of more than 500 million yuan is the combined total of the two funding rounds; the amounts raised in each round and the allocation of funds were not disclosed. It is therefore not possible to judge from the size of the funding alone how much development or clinical research it can support. The change in the investor mix is clear: Puhua Capital led the earlier round, while Shanghai Science and Technology Innovation Group and Minjintou jointly led the later one. However, the identities of the investors do not establish that they will provide business support or clinical resources. The key to understanding this funding in technical terms is the company’s focus on cortical vision restoration and the stages to which it plans to advance development. leaderobot.com reported that the company is pursuing an approach that uses stimulation of the visual cortex. According to a Nov. 8 article by Tencent News, the funding is planned for engineering work on a 1,024-channel vision restoration system, preparation for product type testing and registration testing, and a multicenter clinical study. This points to the importance not only of securing funding but also of bringing the system design to a testable form and moving it into clinical evaluation. Securing funds, however, does not mean that testing has been completed or registration approval obtained. The plan requires more than a device that delivers electrical stimulation: it also calls for matching stimulation conditions with perceptual outcomes and translating that work into evaluable procedures. In vision restoration, the number of channels alone cannot determine success. Key questions for verification include what information is presented under which conditions and what measures are used to confirm perception. The 1,024-channel specification indicates the scale of the development target, but by itself does not demonstrate reproducibility or practical utility. The next points to watch are the amounts raised in each round, the system’s specific configuration, test design and results, and progress in clinical research. The reports disclose the total raised and the lead investors, but not the amounts for each round or how much funding will go to each stage. For now, the total should not be treated as equivalent to development results; what has been demonstrated at each step, from engineering through testing and clinical evaluation, should be tracked separately.

Sources

Translated from the Japanese original: /news/meishi-nou-ki-2-kai-no-shikinchoutatsu-wo-kanryou-ruikei-5-o-1a5065. The Japanese version is authoritative if they differ.